Personalized Virtual Hormone Consultation
A longer starting point for perimenopause, menopause, hormone-related concerns, or questions that may overlap with metabolic health.
Gallagher Medical · Women's health + metabolic health virtual care
Care with Dr. Shauna Gallagher begins with a direct virtual visit that makes room for your experience, history, and goals. Hormonal changes can feel real, disruptive, and varied, and the full clinical picture matters because not every symptom has one cause.
InsuranceCurrently accepting Cigna, Aetna, Anthem, and Emblem plans. Please confirm eligibility and benefits with your plan before booking.
Women's health + metabolic health virtual program
This clinician-led virtual-care pathway supports conversations about women's health, menopause, hormone-related concerns, and metabolic health. It begins with an individualized evaluation rather than a pre-set package.
If ongoing care is clinically appropriate, follow-up timing and visit type are decided with Dr. Gallagher. This is not a subscription, does not include medication or testing by default, and does not guarantee eligibility, prescriptions, or results.
A longer starting point for perimenopause, menopause, hormone-related concerns, or questions that may overlap with metabolic health.
For focused follow-up when it is appropriate for your clinical situation and current care plan.
Virtual visits are for patients located in New York State. Urgent symptoms need emergency or urgent-care evaluation rather than telehealth booking.
View availability on TebraYou may recognize…
These experiences can overlap with other health conditions and deserve clinical evaluation rather than self-diagnosis.
What an evidence-based visit looks like
01
A visit begins with what has changed, how it affects daily life, and what you hope to understand or improve.
02
This can include menstrual changes, medical and family history, medications, risk factors, and relevant records.
03
Together, the conversation may cover appropriate options, questions to consider, and a plan for follow-up when needed.
Care options are not one-size-fits-all
When medication is appropriate, we generally begin with FDA-approved, non-compounded prescription options rather than custom-compounded hormone preparations when an FDA-approved option is available.
Your plan is individualized after a virtual evaluation, medical history review, and shared decision-making. Potential options may include FDA-approved hormonal and nonhormonal prescription treatments for menopause-related symptoms when clinically appropriate and within Dr. Gallagher's scope and clinical protocols.
The consultation is for clinical evaluation and care planning, not for medication sales. If a prescription is appropriate, it is sent electronically to the pharmacy you choose.
A shared decision
Menopause and perimenopause care is personalized around your symptoms, goals, health history, preferences, and what fits practically into your life. The delivery method is a shared decision, not a one-size-fits-all plan.
When clinically appropriate, options may include local vaginal estrogen and systemic formulations such as pills, patches, gels, sprays, and rings. Progesterone may also be considered when appropriate.
In selected circumstances, testosterone may be discussed after individualized evaluation. An IUD may also be part of the conversation for some patients. A virtual visit is a place to weigh these possibilities together; it does not guarantee that any particular treatment or prescription will be recommended.
A little clarity
Hormone-related laboratory testing is not routine or required for everyone with common menopausal symptoms. Through shared decision-making and individualized clinical evaluation, Dr. Gallagher may partner with you to order and review testing when it could be helpful. Results are considered alongside your symptoms, menstrual changes, health history, and goals, not on their own.
When clinically relevant, an evaluation may also consider bone health, including osteopenia or osteoporosis risk. Systemic estrogen can help limit postmenopausal bone loss, while research continues to refine how measured estradiol levels relate to bone outcomes. There is no universal “optimal” estrogen lab value or guarantee of bone protection; treatment, testing, monitoring, and appropriate screening are individualized based on symptoms, history, contraindications, and bone-risk factors.
Questions worth bringing to your visit
These prompts support, not replace, a medical visit.
What has changed?
Which symptoms affect my day-to-day life?
What have I tried so far?
What is relevant in my health and family history?
What are my goals and preferences?
This page is educational only, is not medical advice, does not establish a patient relationship, and is not for urgent concerns. New or urgent chest pain, shortness of breath, fainting, signs of stroke, heavy bleeding, or thoughts of self-harm should receive immediate or emergency evaluation.
Begin with a conversation
Virtual consultations are currently available to patients located in New York State only.
Learn more
Official patient education from ACOG, the FDA, and The Menopause Society.